APP and Alzheimer disease: AβO protein, a critical biomarker for Alzheimer’s disease (AD), is generated through the proteolytic processing of amyloid precursor protein (APP) by β- and γ-secretases, leading to the formation of Aβ40 (non-amyloidogenic) and Aβ42 (amyloidogenic) peptides [18].